LPL Financial
ANIP icon

LPL Financial’s ANI Pharmaceuticals ANIP Stock Holding History

LPL Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,583
Closed -$295K – 3182
2017
Q4 		$295K Hold
4,583
– – ﹤0.01% 2511
2017
Q3 		$241K Hold
4,583
– – ﹤0.01% 2530
2017
Q2 		$214K Sell
4,583
-8
-0.2% -$386 ﹤0.01% 2534
2017
Q1 		$222K Hold
4,591
– – ﹤0.01% 2424
2016
Q4 		$281K Hold
4,591
– – ﹤0.01% 2225
2016
Q3 		$312K Buy
4,591
+500
+12% +$31.3K ﹤0.01% 2087
2016
Q2 		$235K Buy
+4,091
New +$199K ﹤0.01% 2261

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

LPL Financial's ANIP Position: Q1 2018 in Review

LPL Financial sold out of ANI Pharmaceuticals (ANIP) in Q1 2018, closing a stake of 4,583 shares — an estimated $295K sold.

LPL Financial first reported a position in ANIP in Q2 2016 and held it in 7 quarters. The position peaked at $312K in Q3 2016. 175 funds tracked by Wall St. Rank hold ANIP as of Q1 2018.

  • LPL Financial reported no remaining ANI Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • LPL Financial sold 4,583 ANI Pharmaceuticals shares in Q1 2018, an estimated $295K.
  • LPL Financial first reported a position in ANI Pharmaceuticals in Q2 2016 and held it in 7 quarters.
  • LPL Financial's ANI Pharmaceuticals position peaked at $312K in Q3 2016.
  • 175 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2018.

Based on LPL Financial's 13F filing for Q1 2018, filed 15 May 2018.